SPOM
Gerpang Healthcare Group operates as a bio-pharmaceutical company that manufactures and sells genetic coating stents, HBV hepatitis B virus vaccines, monoclonal antibodies for male infertility detection, ognitive disorder functional food, and polypeptide probiotics. The company was founded in 2006 and is based in Jinan, China.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | 0.00 | $0 | — |
| 2025 Q4 | 0.00 | $0 | — |
| 2025 Q2 | 0.00 | $0 | — |
| 2025 Q1 | 0.00 | $243,358 | $20,090 |
| 2024 Q4 | -0.00 | $1M | — |
| 2024 Q2 | -0.00 | $0 | — |
| 2024 Q1 | -0.02 | $0 | -$5M |
| 2023 Q3 | 0.00 | $5M | $770,363 |